During the past decade, Centre Hospitalier de Tarbes conducted 22 clinical trials. In the 10-year time frame, 22 clinical trials started and 3 clinical trials were completed, i.e. on average, 13.6% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 1 clinical trials were completed. i.e. 16.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Centre Hospitalier de Tarbes" #1 sponsor was "University Hospital, Toulouse" with 4 trials, followed by "Federation Francophone de Cancerologie Digestive" with 3 trials sponsored, "Ipsen" with 3 trials sponsored, "Centre Hospitalier Universitaire de Nīmes" with 2 trials sponsored and "Intergroupe Francophone du Myelome" with 2 trials sponsored. Other sponsors include 15 different institutions and companies that sponsored additional 22 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Centre Hospitalier de Tarbes" #1 collaborator was "Ministry of Health, France" with 2 trials as a collaborator, "Agence Régionale de la Santé - Midi Pyrénées" with 1 trials as a collaborator, "Association Clinique Thérapeutique Infantile du val de Marne" with 1 trials as a collaborator, "CENTRE HOSPITALIER COMMINGES PYRENEES" with 1 trials as a collaborator and "Centre Hospitalier Ales" with 1 trials as a collaborator. Other collaborators include 18 different institutions and companies that were collaborators in the rest 28 trials.

According to Clinical.Site data, the most researched conditions in "Centre Hospitalier de Tarbes" are "Pancreatic Cancer" (3 trials), "COVID-19" (2 trials), "Precocious Puberty" (2 trials), "Shock" (2 trials) and "Acute Respiratory Distress Syndrome" (1 trials). Many other conditions were trialed in "Centre Hospitalier de Tarbes" in a lesser frequency.

Most popular intervention types in "Centre Hospitalier de Tarbes" are "Drug" (14 trials), "Other" (10 trials), "Procedure" (4 trials), "Device" (3 trials) and "Behavioral" (1 trials). Other intervention types were less common.

The name of intervention was led by "gemcitabine hydrochloride" (4 trials), "fluorouracil" (3 trials), "leucovorin calcium" (3 trials), "Placebo" (2 trials) and "cisplatin" (2 trials). Other intervention names were less common.

The vast majority of trials in "Centre Hospitalier de Tarbes" are 32 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Centre Hospitalier de Tarbes". undefined are not yet recruiting, 6 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 24 completed trials in Centre Hospitalier de Tarbes, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Centre Hospitalier de Tarbes, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 9 trials that are defined as “Not Applicable".